<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Muehe AM</submitter><funding>Eunice Kennedy Shriver National Institute of Child Health and Human Development</funding><funding>NICHD NIH HHS</funding><pagination>324-335</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5773418</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(2)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>To provide clinically useful gadolinium-free whole-body cancer staging of children and young adults with integrated positron emission tomography/magnetic resonance (PET/MR) imaging in less than 1 h.&lt;h4>Procedures&lt;/h4>In this prospective clinical trial, 20 children and young adults (11-30 years old, 6 male, 14 female) with solid tumors underwent 2-deoxy-2-[&lt;sup>18&lt;/sup>F]fluoro-D-glucose ([&lt;sup>18&lt;/sup>F]FDG) PET/MR on a 3T PET/MR scanner after intravenous injection of ferumoxytol (5 mg Fe/kg) and [&lt;sup>18&lt;/sup>F]FDG (2-3 MBq/kg). Time needed for patient preparation, PET/MR image acquisition, and data processing was compared before (n = 5) and after (n = 15) time-saving interventions, using a Wilcoxon test. The ferumoxytol-enhanced PET/MR images were compared with clinical s</pubmed_abstract><journal>Molecular imaging and biology</journal><pubmed_title>How to Provide Gadolinium-Free PET/MR Cancer Staging of Children and Young Adults in Less than 1 h: the Stanford Approach.</pubmed_title><pmcid>PMC5773418</pmcid><funding_grant_id>R01 HD081123</funding_grant_id><funding_grant_id>R01 HD081123-01A1</funding_grant_id><pubmed_authors>Theruvath AJ</pubmed_authors><pubmed_authors>Aghighi M</pubmed_authors><pubmed_authors>Marina N</pubmed_authors><pubmed_authors>Muehe AM</pubmed_authors><pubmed_authors>Luna-Fineman S</pubmed_authors><pubmed_authors>Quon A</pubmed_authors><pubmed_authors>Holdsworth SJ</pubmed_authors><pubmed_authors>Advani R</pubmed_authors><pubmed_authors>Rosenberg J</pubmed_authors><pubmed_authors>Lai L</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Daldrup-Link HE</pubmed_authors></additional><is_claimable>false</is_claimable><name>How to Provide Gadolinium-Free PET/MR Cancer Staging of Children and Young Adults in Less than 1 h: the Stanford Approach.</name><description>&lt;h4>Purpose&lt;/h4>To provide clinically useful gadolinium-free whole-body cancer staging of children and young adults with integrated positron emission tomography/magnetic resonance (PET/MR) imaging in less than 1 h.&lt;h4>Procedures&lt;/h4>In this prospective clinical trial, 20 children and young adults (11-30 years old, 6 male, 14 female) with solid tumors underwent 2-deoxy-2-[&lt;sup>18&lt;/sup>F]fluoro-D-glucose ([&lt;sup>18&lt;/sup>F]FDG) PET/MR on a 3T PET/MR scanner after intravenous injection of ferumoxytol (5 mg Fe/kg) and [&lt;sup>18&lt;/sup>F]FDG (2-3 MBq/kg). Time needed for patient preparation, PET/MR image acquisition, and data processing was compared before (n = 5) and after (n = 15) time-saving interventions, using a Wilcoxon test. The ferumoxytol-enhanced PET/MR images were compared with clinical s</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Apr</publication><modification>2025-04-04T20:43:41.958Z</modification><creation>2019-08-04T08:21:18Z</creation></dates><accession>S-EPMC5773418</accession><cross_references><pubmed>28721605</pubmed><doi>10.1007/s11307-017-1105-7</doi></cross_references></HashMap>